tirzepatide shortage list FDA Affirms Decision on Resolved, Sets Transition Period for Compounding The FDA recently removed semaglutide

Nakatani Y, Kawabe A, Matsumura M, et al

We handle the complexities of your medical weight loss plan so you can focus on feeling your best and embracing a healthier, more vibrant life

The study uncovered the usual gastrointestinal issues linked to GLP-1 drugs, like abdominal pain, nausea and vomiting, as well as less well-known conditions, including stomach paralysis and diverticulitis, where bulging pouches of the large intestine become inflamed

Recognizing that plateaus are a universal experience and a part of the long-term goal of maintaining weight loss can help individuals make more intentional and adaptive choices in their weight loss journey